FindTrial
Sign In

Effectiveness of a novel traction device in endoscopic submucosal dissection for colorectal lesions

Study on ESD process of colorectal lesions

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040258
Enrollment
Unknown
Registered
2020-11-26
Start date
2020-11-15
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal lesions

Interventions

Experimental group:Intraoperative traction device traction assisted ESD
Control group:conventional ESD

Sponsors

Beijing Chao-yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
33 Years to 84 Years

Inclusion criteria

Inclusion criteria: (1) There is no indication for endoscopic treatment of colorectal carcinoma. (2) The relative indication was SM1 carcinoma with mild submucosal infiltration (the depth of submucosal infiltration <= 1000 um).

Exclusion criteria

Exclusion criteria: (1) It is impossible to stop anticoagulant or antiplatelet drugs; (2) Active infection; pregnancy or lactation; (3) Severe mental disorders; unstable hypertension, heart disease or uncontrolled diabetes mellitus; (4) And subjects that the researchers considered inappropriate.

Design outcomes

Primary

MeasureTime frame
submucosal dissection speed;—

Secondary

MeasureTime frame
The total procedure time;submucosal dissection time;—

Countries

China

Contacts

Public ContactHao Jianyu

Beijing Chao-yang Hospital, Capital Medical University,

xiaoliu_endoscopy@126.com+86 18101066642

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026